NATIONAL RESEARCH CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NATIONAL RESEARCH CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $119.69M | Mar 8, 2019 |
| FY2018 | Dec 31, 2017 | $117.56M | Mar 8, 2019 |
| FY2018 | Dec 31, 2016 | $109.38M | Mar 8, 2019 |
| FY2017 | Dec 31, 2015 | $102.34M | Mar 14, 2018 |
| FY2016 | Dec 31, 2014 | $98.84M | Mar 3, 2017 |
| FY2015 | Dec 31, 2013 | $92.59M | Mar 4, 2016 |
| FY2014 | Dec 31, 2012 | $86.42M | Mar 4, 2015 |
| FY2013 | Dec 31, 2011 | $75.77M | Mar 4, 2014 |
| FY2012 | Dec 31, 2010 | $63.40M | Mar 1, 2013 |
| FY2011 | Dec 31, 2009 | $57.69M | Mar 1, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $137.39M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $143.06M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $148.58M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $151.57M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $147.95M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $133.28M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $127.98M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $119.69M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $117.56M | Mar 6, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $30.05M | Mar 8, 2019 |
| FY2017 | Dec 31, 2017 | $22.94M | Mar 14, 2018 |
| FY2017 | Dec 31, 2016 | $20.52M | Mar 14, 2018 |
| FY2017 | Dec 31, 2015 | $17.61M | Mar 14, 2018 |
| FY2016 | Dec 31, 2014 | $18.16M | Mar 3, 2017 |
| FY2015 | Dec 31, 2013 | $15.48M | Mar 4, 2016 |
| FY2014 | Dec 31, 2012 | $15.07M | Mar 4, 2015 |
| FY2013 | Dec 31, 2011 | $11.56M | Mar 4, 2014 |
| FY2013 | Dec 31, 2010 | $11.56M | Mar 4, 2014 |
| FY2011 | Dec 31, 2009 | $8.49M | Mar 1, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.59M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $35.19M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $40.05M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $46.54M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $50.27M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $42.68M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $43.04M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $35.28M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $34.22M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $31.20M | Mar 8, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.81M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $44.91M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $46.62M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $42.70M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $38.96M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $34.44M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $32.97M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $31.37M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $29.69M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $28.39M | Mar 8, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.45M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $34.63M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $38.11M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $36.27M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $46.34M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $40.64M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $40.92M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $39.85M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $28.09M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $26.84M | Mar 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.71M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $15.45M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $15.78M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $9.84M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $5.51M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $3.98M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $4.66M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $5.97M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $4.57M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $3.97M | Mar 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.88M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $132.54M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $122.44M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $130.46M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $157.54M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $133.42M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $110.69M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $108.03M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $127.32M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $120.62M | Mar 8, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.89M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $101.26M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $73.48M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $58.43M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $72.20M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $69.11M | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $77.79M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $88.95M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $37.28M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $37.82M | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.99M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $31.28M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $48.96M | Mar 5, 2026 |
| FY2025 | Dec 31, 2022 | $72.03M | Mar 5, 2026 |
| FY2024 | Dec 31, 2021 | $85.34M | Mar 17, 2025 |
| FY2023 | Dec 31, 2020 | $64.32M | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $32.89M | Mar 3, 2023 |
| FY2021 | Dec 31, 2018 | $19.08M | Mar 4, 2022 |
| FY2020 | Dec 31, 2017 | $90.04M | Mar 5, 2021 |
| FY2019 | Dec 31, 2016 | $82.81M | Mar 6, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.15M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $66.15M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $61.61M | Mar 5, 2026 |
| FY2023 | Dec 31, 2022 | $61.61M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $61.61M | Mar 3, 2023 |
| FY2022 | Dec 31, 2020 | $57.26M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $57.94M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $57.83M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $58.02M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $57.86M | Mar 8, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.30M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($17.06M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($30.53M) | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | ($25.18M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($36.11M) | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | ($61.38M) | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | ($93.36M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($106.34M) | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $77.57M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $71.51M | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $4.23M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $6.65M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $25.03M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $54.36M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $34.69M | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $13.52M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $12.99M | Mar 6, 2020 |
| FY2019 | Dec 31, 2017 | $34.73M | Mar 6, 2020 |
| FY2019 | Dec 31, 2016 | $33.02M | Mar 6, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $36.79M | Feb 27, 2024 |
| FY2023 | Dec 31, 2022 | $22.32M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $26.62M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | $30.71M | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | $34.28M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $37.97M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $1.07M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $3.54M | Mar 14, 2018 |
| FY2016 | Dec 31, 2015 | $5.74M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | $8.07M | Mar 4, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 50 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 4, 2022 |
| FY2012 | Dec 31, 2012 | 2 | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | 1 | Mar 1, 2013 |
| FY2012 | Dec 31, 2010 | 1 | Mar 1, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 50 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 4, 2022 |
| FY2012 | Dec 31, 2012 | 2 | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | 1 | Mar 1, 2013 |
| FY2012 | Dec 31, 2010 | 1 | Mar 1, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22.64M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 23.08M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 24.22M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 24.63M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 25.36M | Mar 3, 2023 |
| FY2021 | Dec 31, 2020 | 25.39M | Mar 4, 2022 |
| FY2020 | Dec 31, 2019 | 24.95M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | 24.80M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | 20.94M | Mar 8, 2019 |
| FY2012 | Dec 31, 2012 | 6.87M | Mar 1, 2013 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.98M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $11.45M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $36.37M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $20.96M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $9.16M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $10.52M | Mar 3, 2023 |
| FY2021 | Dec 31, 2019 | $31.30M | Mar 4, 2022 |
| FY2020 | Dec 31, 2018 | $16.86M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $16.87M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $28.55M | Mar 8, 2019 |